Zamaneh Mikhak's most recent trade in Tff Pharmaceuticals Inc was a trade of 10,184 Common Stock done . Disclosure was reported to the exchange on July 3, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Tff Pharmaceuticals Inc | Zamaneh Mikhak | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 10,184 | 145,184 (0%) | 0% | 0 | Common Stock | |
Tff Pharmaceuticals Inc | Zamaneh Mikhak | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 10,184 | 10,184 | - | - | Stock Options (Right to Buy) | |
Tff Pharmaceuticals Inc | Zamaneh Mikhak | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 10,600 | 10,600 | - | - | Restricted stock units | |
Tff Pharmaceuticals Inc | Zamaneh Mikhak | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 5,300 | 5,300 | - | - | Restricted stock units | |
Tff Pharmaceuticals Inc | Zamaneh Mikhak | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 15 Aug 2023 | 120,000 | 135,000 (0%) | 0% | 0.3 | 30,000 | Common Stock |
Tff Pharmaceuticals Inc | Zamaneh Mikhak | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.82 per share. | 10 Mar 2023 | 15,000 | 15,000 (0%) | 0% | 0.8 | 12,300 | Common Stock |